Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Administered as a once-weekly subcutaneous injection, Wegovy works by mimicking the naturally occurring hormone GLP-1, which regulates appetite and food intake through actions on the brain's satiety centres
A 2023 analysis of the SUSTAIN and PIONEER trials published in Cardiovascular Diabetology showed significant reductions in high-sensitivity C-reactive protein, a marker of systemic inflammation, among patients taking semaglutide
While Mounjaro and Ozempic are both GLP-1 receptor agonists used to treat diabetes and support weight loss, they are not the same
Therefore, switching from semaglutide to tirzepatide may be very beneficial
US$ 23.55
US$ 25.97
US$ 29.57
US$ 25.74
